-
12881por Maiese, Kenneth“…Furthermore, pathways that can activate mTOR may be necessary for anti-hepatitis C activity, reduction of influenza A virus replication, and vital for type-1 interferon responses with influenza vaccination. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12882“…Platelet activation is a common event in many viral infections including human immunodeficiency virus (HIV), H1N1 influenza, Hepatitis C virus (HCV), Ebola virus (EBV), and Dengue virus (DENV). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12883por Awad, Mahmoud E., Borrego-Sánchez, Ana, Escamilla-Roa, Elizabeth, Hernández-Laguna, Alfonso, Sainz-Díaz, C. Ignacio“…This work aimed at studying the potentiality of interactions between kaolinite surfaces and a protein-fragment (350–370 amino acid units) extracted from the glycoprotein E1 in the transmembrane domain (TMD) of hepatitis C virus capsid. A computational work was performed for locating the potential electrostatic interaction sites between kaolinite aluminol and siloxane surfaces and the residues of this protein-fragment ligand, monitoring the possible conformational changes. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12884“…The association between hepatitis C virus (HCV) and sarcoidosis is well-documented, but in this case report, we shall discuss an interesting association between hepatitis B virus (HBV) and sarcoidosis, presenting with non-specific symptoms and confirmed with liver biopsy and immunologic markers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12885por Fournier, Anna Lucie, Parienti, Jean-Jacques, Champenois, Karen, Feret, Philippe, Papot, Emmanuelle, Yazdanpanah, Yazdan, Verdon, Renaud“…The independent risk factors for MCI were a linkage to care >6 months after HIV diagnosis (hazard ratio [HR] = 1.14; 95% CI = 1.08–1.21), a hepatitis C coinfection (HR = 1.76; 95% CI = 1.07–2.88), being born in Sub-Saharan Africa (HR = 2.18; 95% CI = 1.42–3.34 vs. in France) and not having a mailing address reported in the file (HR = 1.73; 95% CI = 1.07–2.80). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12886por Restrepo, Clara, Álvarez, Beatriz, Valencia, José L, García, Marcial, Navarrete-Muñoz, María A, Ligos, José M, Cabello, Alfonso, Prieto, Laura, Nistal, Sara, Montoya, María, Górgolas, Miguel, Rallón, Norma, Benito, José M“…(1) Background: The role of hepatitis C virus (HCV) co-infection on the T-cell homeostasis disturbances in human immunodeficiency virus (HIV)-infected patients as well as its reversion after HCV eradication with direct acting antivirals (DAAs) therapy has not been yet clarified. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12887por Al-Naamani, Khalid, Al-Hashami, Zamzam, Al-Siyabi, Omar, Al-Moundri, Mansour, Al-Bahrani, Bassim, Al-Sinani, Siham, Al-Zakwani, Ibrahim, Omar, Heba, Al-Busafi, Said A., Al-Zuhaibi, Haifa, AlMamari, Abdullah, Kamath, Bola R., Al-Kalbani, Abdullah, Burney, Ikram Ali“…The majority had liver cirrhosis (79.9%), with the most common aetiologies being chronic hepatitis C (46.5%) and B (43.2%). Only 13.7% of cases were detected by the HCC surveillance programme. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12888por Tamori, Akihiro, Uchida‐Kobayashi, Sawako, Kozuka, Ritsuzo, Motoyama, Hiroyuki, Yoshida, Kanako, Odagiri, Naoshi, Kotani, Kohei, Kawamura, Etsushi, Fujii, Hideki, Hagihara, Atsushi, Enomoto, Masaru, Kawada, Norifumi“…BACKGROUND AND AIM: We assessed direct‐acting antiviral (DAA) treatment for patients with hepatitis C virus (HCV) and a history of injection drug use (IDU) in Japan. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12889por Neves, Precil D., Bridi, Ramaiane A., Ramalho, Janaína A., Jorge, Lectícia B., Watanabe, Elieser H., Watanabe, Andreia, Yu, Luis, Woronik, Viktoria, Pinheiro, Rafaela B., Testagrossa, Leonardo A., Cavalcante, Lívia B., Malheiros, Denise M., Dias, Cristiane B., Onuchic, Luiz F.“…Laboratory tests revealed serum creatinine 1.89mg/dL, blood urea nitrogen (BUN) 24mg/dL, albumin 1.9g/dL, cholesterol 531mg/dL, low-density lipoprotein 426mg/dL, platelets 115000/mm(3), normal C3/C4, antinuclear antibody (ANA), rheumatoid factor (RF), and antineutrophil cytoplasmic antibodies (ANCA), negative serologies for hepatitis C virus (HCV) and human immunodeficiency virus (HIV), HBsAg negative and AntiHBc IgG positive, no hematuria or leukocyturia, 24 hour proteinuria 6.56g and negative serum and urinary immunofixation. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12890por Roy, Subhajit, Roy, Debarati Guha, Bhushan, Anand, Bharatiya, Seema, Chinnaswamy, Sreedhar“…Previous genetic studies, in the context of hepatitis C virus infections, had predicted three regulatory SNPs: rs4803219, rs28416813 and rs4803217 that could have functional/causal roles. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12891por Hamida, Reham Samir, Shami, Ashwag, Ali, Mohamed Abdelaal, Almohawes, Zakiah Nasser, Mohammed, Afrah E., Bin-Meferij, Mashael Mohammed“…Kefir and its probiotic contents can modulate the immune system to suppress infections from viruses (e.g., Zika, hepatitis C, influenza, rotaviruses). The antiviral mechanisms of kefir involve enhancement of macrophage production, increasing phagocytosis, boosting production of cluster of differentiation-positive (CD4(+)), CD8(+), immunoglobulin (Ig)G(+) and IgA(+) B cells, T cells, neutrophils, as well as cytokines (e.g., interleukin (IL)-2, IL-12, interferon gamma-γ). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12892“…RESULTS: Based on our literature research, there are several infectious agents which cause similar disease manifestations to Sjögren’s syndrome, including infections of hepatitis C virus, Epstein–Barr virus, cytomegalovirus, and human T-lymphotropic virus-1 (HTLV-1), and these four agents are found to cause persistent infection on the salivary gland after the first infection and later lead to organ destruction, thus causing sicca syndrome in the oral cavity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12893“…BACKGROUND: The mixed cryoglobulinemia (MC) syndrome is a systemic inflammatory syndrome that causes small-to-medium vessel vasculitis due to cryoglobulin-containing immune complexes most commonly caused by chronic hepatitis C virus (HCV), and rarely by chronic hepatitis B virus (HBV). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12894por Porter, Ashleigh F, Pettersson, John H -O, Chang, Wei-Shan, Harvey, Erin, Rose, Karrie, Shi, Mang, Eden, John-Sebastian, Buchmann, Jan, Moritz, Craig, Holmes, Edward C“…The Flaviviridae family of positive-sense RNA viruses contains important pathogens of humans and other animals, including Zika virus, dengue virus, and hepatitis C virus. The Flaviviridae are currently divided into four genera—Hepacivirus, Pegivirus, Pestivirus, and Flavivirus—each with a diverse host range. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12895“…Furthermore, three of the top 30 drugs with strong affinity prediction for the TMPRSS2 are anti-hepatitis C virus (HCV) drugs, including ombitasvir, daclatasvir, and paritaprevir. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12896“…In Japan, ~3 million individuals are estimated to be infected with hepatitis B virus (HBV) or hepatitis C virus (HCV). The rates of hepatitis virus infection amongst dentists is higher than that amongst other healthcare workers due to increased exposure to both saliva and blood. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12897por Mekonnen, Zelalem A., Masavuli, Makutiro G., Yu, Wenbo, Gummow, Jason, Whelan, Dawn M., Al-Delfi, Zahraa, Torresi, Joseph, Gowans, Eric J., Grubor-Bauk, Branka“…A vaccine that induces potent, broad and sustained cell-mediated immunity, resulting in effective memory has the potential to restrict hepatitis C (HCV) virus infection. Early, multi-functional CD4(+) and CD8(+) T cell responses against non-structural protein 3 (NS3) have been associated with HCV clearance. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12898por Ryom, L, Cotter, A, De Miguel, R, Béguelin, C, Podlekareva, D, Arribas, JR, Marzolini, C, Mallon, PGM, Rauch, A, Kirk, O, Molina, JM, Guaraldi, G, Winston, A, Bhagani, S, Cinque, P, Kowalska, JD, Collins, S, Battegay, M“…It was specified to use urine albumin to creatinine ratio to screen for glomerular disease and urine protein to creatinine ratio for tubular diseases, and thresholds were streamlined with the Kidney Disease: Improving Global Outcomes (KDIGO) recommendations. Hepatitis C virus (HCV) treatment recommendations were split into preferred and alternative treatment options. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12899por Peyvandi, Flora, Mahlangu, Johnny N., Pipe, Steven W., Hay, Charles R. M., Pierce, Glenn F., Kuebler, Peter, Kruse‐Jarres, Rebecca, Shima, Midori“…PATIENTS/METHODS: All fatalities in PwcHA reported to the database (from clinical trials, pre‐market access, and spontaneous post‐marketing reports) were categorized into: associated with hemophilia A—hemorrhagic, thrombotic, human immunodeficiency virus (HIV)/hepatitis C virus (HCV), hepatic (non‐HCV); associated with general population—trauma/suicide, non‐HA‐associated conditions; or, unspecified. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12900por Pipe, Steven W., Kruse‐Jarres, Rebecca, Mahlangu, Johnny N., Pierce, Glenn F., Peyvandi, Flora, Kuebler, Peter, De Ford, Christian, Sanabria, Fabián, Ko, Richard H., Chang, Tiffany, Hay, Charles R. M.“…Causes associated with HA include hemorrhage, thrombosis, human immunodeficiency virus, hepatitis C virus, and liver dysfunction. We propose an algorithm employing these classes to categorize fatalities and use it to classify FAERS fatality data between 01/01/2000 and 03/31/2020; the most common causes were hemorrhage (22.2%) and thrombosis (10.4%). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto